Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
Selank structure

Selank

Cognitive
Phase 2 Research
55%
Low Risk
1/5

Dosing Protocol

Typical Dose 500 mcg
Range 250 - 750 mcg
Maintenance 500 mcg 2-3x daily

Pharmacokinetics

Half-Life 3 min
Onset 2 min
Peak 10 min
Duration 3.0 hrs
Bioavailability 92%
Primary Route Nasal

Administration

Routes Nasal, Subcutaneous
Syringe Type Nasal Spray
Timing Morning, afternoon

Reconstitution

Diluent Bacteriostatic Water
Volume 3 mL
Concentration 1667 mcg/mL
Stability 30 days refrigerated
Vial Sizes 5 mg

Special Instructions

Nasal spray preferred. Each spray typically delivers 50-100mcg. No tolerance or dependence reported.